FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTCBB: VYHN.OB), makers of LidoSite®, the first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration (FDA), today announced promotions of five current members of the executive team to more accurately reflect and focus the Company’s commitment to its recently announced business strategy for near-term sales growth and profitability.
